基于Logistic回归的老年人APP用户体验优化设计

目的 提升老年人APP的用户体验水平。方法 提出一种基于Logistic回归的老年人APP用户体验优化设计研究方法。首先，通过文献研究和焦点小组法确定APP的设计模式，并选择合适的正交表确定设计模式的组合方式；其次，构建以行为体验、感知体验和情感体验为基础的用户体验评价体系，邀请被试者对试验样本执行具有代表性的任务，并对用户体验进行评价研究，收集试验数据；再次，运用序次Logistic回归建立APP设计模式与用户体验之间的关系模型，确定APP的最佳设计方案；最后，运用A/B测试方法对得到的试验结果进行验证。结论 以老年人移动医疗APP为例进行研究，结果表明所提出的方法可以有效地对老年人APP的用户体验进行优化设计，有助于设计师了解老年用户的偏好，设计出适合老年人使用的APP。     

基于章水泉竹艺非物质文化遗产的APP设计与研究

目的 针对章水泉竹艺非物质文化遗产在目前所遭遇的传承困境，利用数字媒体技术与互联网平台，打造推动其产品创新与文化传承的APP，助力其文化与产品的传播与推广，进而为湖北地区的非遗文化发展提供参考。方法 从章水泉竹器的本源出发，对其主要产品门类、工艺特点与艺术形式进行整理与分类，分析制约其传承与发展的主要原因，进而提出设计策略，并通过数字化传承、合作创新、成果推广3个策略模块针对性地进行APP设计。结论 章水泉竹艺APP设计通过利用数字媒体技术与互联网平台优势，将其历史与工艺资料进行数字化保存与展示，实现了文化保护功能；将其传统技艺与新锐设计思维通过线上平台进行融合与创新，实现了设计创新功能；将其制作流程与文化精髓通过直播与精准推送展现于公众视野，实现了产品推广功能。最终，为章水泉竹艺的传承与推广提供了新的路径。     

就诊等待服务APP适老化设计研究

目的 将数字化服务融入老年患者就诊流程，建立适老化就诊等待服务系统，在APP开发设计研究中实现软件流程优化。方法 依据ERG理论对老年患者在就诊等待过程中的需求点进行分类整理和层次划分。调研目标用户将分析结果融入服务设计理论，为指导软件开发所涉及的医院就诊流程、用户需求痛点，提出系统性的解决策略。基于交互设计原则展开APP界面设计。结论 构建了以老年患者为中心的就诊等待服务系统，帮助提升其等待过程中的自我效能。完善了基于产品使用方式层级的适老化就诊等待服务APP设计策略，为适老化、数字化产品研发提供了新思路;最终产出APP设计实例，提高了老年群体社会参与度，鼓励老年患者自主就诊，帮助其更加轻松地享受信息化时代带来的红利。     

Meta-Analysis of Methamphetamine Modulation on Amyloid Precursor Protein through HMGB1 in Alzheimer’s Disease

The deposition of amyloid-beta (Aβ) through the cleavage of amyloid-beta precursor protein (APP) is a biomarker of Alzheimer’s disease (AD). This study used QIAGEN Ingenuity Pathway Analysis (IPA) to conduct meta-analysis on the molecular mechanisms by which methamphetamine (METH) impacts AD through modulating the expression of APP. All the molecules affected by METH and APP were collected from the QIAGEN Knowledge Base (QKB); 78 overlapping molecules were identified. Upon simulation of METH exposure using the “Molecule Activity Predictor” feature, eight molecules were found to be affected by METH and exhibited activation relationships on APP expression at a confidence of p = 0.000453 (Z-score = 3.51, two-tailed). Core Analysis of these eight molecules identified High Mobility Group Box protein 1 (HMGB1) signaling pathway among the top 5 canonical pathways with most overlap with the 8-molecule dataset. Simulated METH exposure increased APP expression through HMGB1 at a confidence of p < 0.00001 (Z-score = 7.64, two-tailed). HMGB1 is a pathogenic hallmark in AD progression. It not only increases the production of inflammatory mediators, but also mediates the disruption of the blood-brain barrier. Our analyses suggest the involvement of HMGB1 signaling pathway in METH-induced modulation of APP as a potential casual factor of AD.     

基于GPS和WiFi的室内外定位系统的设计与实现

经济和科技高速发展的中国,基于GPS的定位技术和基于WiFi的定位技术已发展成熟。在有14亿人口的中国,人们的思想观念发生了巨大变化,人口老龄化越来越严重,老人和小孩等弱势群体走失事件频发。因此,借助定位技术缓解这种现象十分必要。借助定位信息,不仅可以缓解老人小孩走失问题,而且可以实现前签到等功能。定位技术的应用范围和发展前景非常广阔。     

APP软件性能效率研究

性能效率是APP软件的重要质量属性，但目前缺乏APP软件性能效率的通用模型。分析了APP软件的性能特征，基于ISO/IEC 25010标准提出了APP软件的性能效率模型，定义了APP软件性能效率的子特性和度量指标。基于提出的APP软件性能效率模型，通过实验对APP软件的性能效率进行了度量及相关分析。     

Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model

Therapeutic approaches providing effective medication for Alzheimer’s disease (AD) patients after disease onset are urgently needed. Previous studies in AD mouse models suggested that physical exercise or changed lifestyle can delay AD-related synaptic and memory dysfunctions when treatment started in juvenile animals long before onset of disease symptoms, while a pharmacological treatment that can reverse synaptic and memory deficits in AD mice was thus far not identified. Repurposing food and drug administration (FDA)-approved drugs for treatment of AD is a promising way to reduce the time to bring such medication into clinical practice. The sphingosine-1 phosphate analog fingolimod (FTY720) was approved recently for treatment of multiple sclerosis patients. Here, we addressed whether fingolimod rescues AD-related synaptic deficits and memory dysfunction in an amyloid precursor protein/presenilin-1 (APP/PS1) AD mouse model when medication starts after onset of symptoms (at five months). Male mice received intraperitoneal injections of fingolimod for one to two months starting at five to six months. This treatment rescued spine density as well as long-term potentiation in hippocampal cornu ammonis-1 (CA1) pyramidal neurons, that were both impaired in untreated APP/PS1 animals at six to seven months of age. Immunohistochemical analysis with markers of microgliosis (ionized calcium-binding adapter molecule 1; Iba1) and astrogliosis (glial fibrillary acid protein; GFAP) revealed that our fingolimod treatment regime strongly down regulated neuroinflammation in the hippocampus and neocortex of this AD model. These effects were accompanied by a moderate reduction of Aβ accumulation in hippocampus and neocortex. Our results suggest that fingolimod, when applied after onset of disease symptoms in an APP/PS1 mouse model, rescues synaptic pathology that is believed to underlie memory deficits in AD mice, and that this beneficial effect is mediated via anti-neuroinflammatory actions of the drug on microglia and astrocytes.     

New Insights to Clathrin and Adaptor Protein 2 for the Design and Development of Therapeutic Strategies

The Amyloid Precursor Protein (APP) has been extensively studied for its role as the precursor of the β-amyloid protein (Aβ) in Alzheimer’s disease (AD). However, our understanding of the normal function of APP is still patchy. Emerging evidence indicates that a dysfunction in APP trafficking and degradation can be responsible for neuronal deficits and progressive degeneration in humans. We recently reported that the Y₆₈₂ mutation in the ₆₈₂YENPTY₆₈₇ domain of APP affects its binding to specific adaptor proteins and leads to its anomalous trafficking, to defects in the autophagy machinery and to neuronal degeneration. In order to identify adaptors that influence APP function, we performed pull-down experiments followed by quantitative mass spectrometry (MS) on hippocampal tissue extracts of three month-old mice incubated with either the ₆₈₂YENPTY₆₈₇ peptide, its mutated form, ₆₈₂GENPTY₆₈₇ or its phosphorylated form, ₆₈₂pYENPTY₆₈₇. Our experiments resulted in the identification of two proteins involved in APP internalization and trafficking: Clathrin heavy chain (hc) and its Adaptor Protein 2 (AP-2). Overall our results consolidate and refine the importance of Y₆₈₂ in APP normal functions from an animal model of premature aging and dementia. Additionally, they open the perspective to consider Clathrin hc and AP-2 as potential targets for the design and development of new therapeutic strategies.     

一种基于NFC的无源智能锁及其在配电网中的应用

针对配网柜体采用的传统机械锁具管理难度大、破解容易以及可追踪性差,无法满足现代电网快速发展的多样化需求等问题。该文研制了一种基于配电物联网架构的无源高可靠性智能电子锁。其内嵌安全芯片,采用近场通信(Near Field Communication,NFC)技术完成通信及取能,无需机械钥匙开锁,无需维护更换锁具电池,并配套开发了能够实时监测锁具状态、储存开锁信息的智能锁管理系统以及配合开锁APP使用的电子钥匙,分析了智能锁具的硬件设计及系统的应用流程。最后,通过实践应用表明,该套锁具系统在运维便捷、信息安全和科学管理方面具有明显效用。     

智能网联汽车APP中控制模块的视觉设计与应用

目的研究智能网联汽车手机APP中控制模块的视觉设计与应用,强化视觉设计过程的合理性,为智能汽车HMI设计实践工作提供启示与借鉴。方法首先从用户体验的角度分析APP控制模块存在的视觉设计问题,主要是视觉结构单一、视觉层级混乱、视觉特征缺失,再从行为逻辑的角度思考视觉设计方法,"由面及点"地提出控制模块的视觉设计思路,并结合设计应用案例论证其可行性。结果从合理视觉布局、明确视觉层级和提炼视觉语言的角度提出APP控制模块的视觉设计思路。结论智能网联汽车APP控制模块的视觉设计应该重视行为逻辑的影响。从任务角度思考视觉布局、从行为逻辑的角度思考视觉层级、从行为特征的角度思考视觉语言,提高视觉设计工作的合理性,减少与交互设计工作脱节的现象,强化控制求助的高效性和安全性。